Showing 113 of 113on this page. Filters & sort apply to loaded results; URL updates for sharing.113 of 113 on this page
Ardelyx Launches 'Can We Do Better?' Campaign at ASN's Kidney Week 2020
Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For ...
Ardelyx Reports First Quarter 2017 Operating Results and Highlights ...
Ardelyx Inc (NASDAQ:ARDX) Pleases Investors With Phase 3 Results Of ...
Working at Ardelyx | Glassdoor
Ardelyx - Crunchbase Company Profile & Funding
ARDX Insider Trading | Ardelyx Buys and Sells
Ardelyx (ARDX): A Promising Biotech Penny Stock for Your Portfolio
Ardelyx (NASDAQ:ARDX) Share Price Crosses Below 50-Day Moving Average ...
Ardelyx | NEA | New Enterprise Associates
Is Ardelyx is A Buy After Slip in Early 2022 | MarketBeat
Ardelyx announces publication of a review article demonstrating rapid ...
Ardelyx Shares Surge on Promising Clinical Trial Results - Stocks Today
How Does Ardelyx Company Work? – PortersFiveForce.com
Ardelyx Inc (ARDX) News, Articles, Events & Latest Updates
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Acceptance ...
Ardelyx (ARDX) Resubmits New Drug Application to FDA. | Internet ...
Ardelyx Inc. (ARDX) Soars 8.26% on April 08 – Biotech Insider
Press Release: Ardelyx Announces FDA Plan to Convene Advisory Committee ...
Adding Ardelyx (ARDX) $1.57 to Watch List. | Internet | Biotech Stock ...
Ardelyx Q2 Revenue Surges 33% to $98M, Raises 2025 Guidance | ARDX ...
Ardelyx Surpasses Expectations with Remarkable Q2 Performance
Ardelyx Announces Publication of a Review Article Demonstrating Rapid ...
Ardelyx (ARDX) Tops Q3 With $110.33M Revenue • BioTech Health X
Ardelyx – Folio Architects
Press Release: Ardelyx Announces FDA Acceptance and Six-Month Review ...
After long journey, Ardelyx gets FDA OK for kidney disease drug ...
Ardelyx (ARDX) Up on FDA Nod to Xphozah for Hyperphosphatemia
Home - Ardelyx
Ardelyx finally gets its approval
Ardelyx (ARDX) $3.40, Receives FDA Approval. | Internet | Biotech Stock ...
Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT
How to Buy Ardelyx Stock [2026] | Invest in ARDX
Ardelyx Announces Changes to the Executive Leadership Team
What is Brief History of Ardelyx Company? – PortersFiveForce.com
Ardelyx to Receive $5M Milestone Payment as Japan Partner Initiates Phase 3
Ardelyx ARDX 1Q 2023 Summary 08May2023 - YouTube
Ardelyx Inc (ARDX) Reports Robust Revenue Growth and Strategic A
Press Release: Ardelyx Shares Positive Data and hosts IBS-C Product ...
Ardelyx, Inc. on LinkedIn: Ardelyx announces a new treatment option for ...
Ardelyx Appoints Eric Foster as Chief Commercial Officer
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces Publication ...
SCM24: How tenapanor boosts serum phosphate | Ardelyx Medical posted on ...
Ardelyx (NASDAQ:ARDX): A Commercial-Stage Biopharma Stock with Growth ...
Ardelyx on Twitter: "Press Release: Ardelyx to Present at the Jefferies ...
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Announces FDA ...
Ardelyx Stock Surges Amid Upgraded Ratings and Revenue Projections
Ardelyx Careers | Levels.fyi
Ardelyx Stock: Big Transitional Period (NASDAQ:ARDX) | Seeking Alpha
Ardelyx Stock (ARDX) Opinions on Insider Sale and CMS Case | Quiver ...
Ardelyx (ARDX) Stock Soared 59% on FDA Panel’s Positive Ruling
We’re excited to announce the launch of our Ardelyx Medical page! We ...
ARDX - Ardelyx | Fundamentei
Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue ...
Ardelyx (ARDX) CFO Form 3: 146,896 RSUs, 578,104 option | ARDX SEC ...
Ardelyx Inc (ARDX) Q3 2025 Earnings Call Highlights: Strong Revenue ...
Ardelyx – Annual Dialysis Conference
Ardelyx logo in transparent PNG and vectorized SVG formats
Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and ...
Ardelyx (ARDX) FDA Approvals, PDUFA Dates & Drug Alerts 2026
Ardelyx to Raise $110 Million in a Private Placement
Cantor ups Ardelyx to OW; PT to $10 ahead of October PDUFA date ...
Ardelyx names Rajani Dinavahi as CMO | The Pharmaletter
What is Growth Strategy and Future Prospects of Ardelyx Company ...
Ardelyx Presents Data that Continues to Support the
Ardelyx Inc (ARDX) Fundamental & Financial Data
Ardelyx, Inc. on LinkedIn: Press Release: Ardelyx Launching IBSRELA ...
Ardelyx Touts IBSRELA’s 73% Growth, Reaffirms $1B 2029 Goal and Details ...
Ardelyx - Teams | The Org
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma ...
Ardelyx 2026 Company Profile: Stock Performance & Earnings | PitchBook
#ARDX - Why Ardelyx Stock Is Dropping Benzinga | Market Wire News
Ardelyx - National Health Council
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report ...
Ardelyx (ARDX) Up on Xphozah's Orphan Tag for Hyperphosphatemia
Ardelyx Announces Recipients of the 2026 Derek Forfang
48 New Drug FDA Approvals in 2019
Ardelyx, Inc. (Ardelyx, Inc.) - 药物管线_专利_临床试验_投融营收_最新药物:盐酸替那帕诺
LOGO
Logos of pharmaceutical companies
We're excited to share our new clinical trials website, where patients ...
ARDX | Ardelyx, Inc. Stock Data, Price & News
Ardelyx's Stellar Q4 Performance: A Beacon of Growth in Biopharma
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
Ardelyx, Inc. 2023 Q2 - Results - Earnings Call Presentation (NASDAQ ...
Ardelyx, Inc. (ARDX) BCG Matrix Analysis – DCFmodeling.com
Ardelyx, Inc. (ARDX) Stock Price, News, Quote & History - Yahoo Finance
Ardelyx, Inc. Q4 2025 Earnings Call Summary
Ardelyx, Inc. on LinkedIn: Save the date! We will present first quarter ...
Ardelyx, Inc. on LinkedIn: Save the date! We will present financial ...
At Ardelyx, we act on opportunities that reinforce our collective ...
FDA Signals Unclear Clinical Benefits Of Ardelyx's Kidney Disease Candidate
Projects — Hisel Flynn Architects
Save the date! Today we announced that management will present at TD ...
#ardelyxproud #scm24 | Ardelyx, Inc.
Picture 3
Heroes in Health 30th Anniversary Celebration - Alliance for Aging Research
ardx-20240930
Ardelyx-Ardelyx, Inc.-企业详情-InvestGO数据库-ByDrug-医药魔方数据库
Ardelyx, Inc. Careers
商用阶段的生物制药公司：Ardelyx, Inc.(ARDX) | 美股之家 - 港股美股开户投资百科全书
2026 Patient Symposium | National Kidney Foundation
2025 Patient Symposium | National Kidney Foundation
